MDGL Shares Hit a Fresh 52-Week Low Amid Profitability Concerns
Madrigal Pharmaceuticals shares fell to a fresh 52-week low as investors weighed management’s warning that its first quarterly profit may not be durable amid commercial investments. Citi sees over 75% upside, according to the headline.
Shares of Madrigal Pharmaceuticals (MDGL) declined on Tuesday, hitting a fresh 52-week low, even as the company reported its first quarterly profit, as investors focused on management’s comments that profitability may not prove durable in the near term amid ongoing commercial investments.MDGL share…